Address
Email address
Phone number
https://aaskla.eeMeditsiinitarvikud, maaletoomine ja edasimüük - Aaskla Medicalmeditsiinitarvikud, maaletoomine ja edasimüük. Günekoloogia, intensiivravi, desinfektsioon, kirurgia, uroloogia, ravimid, puhastusvahendid jpm.
Name
AASKLA osaühing
Registry code
10965402
VAT number
EE100848133
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
09.09.2003 (21)
Financial year
01.01-31.12
Capital
4 077.00 €
Activity
46461 - Wholesale of medicines and other pharmacy goods
-
-
-
-
-
-
Not submitted
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Ave Karjust 03.12.1981 (42) | 20% - 818.00 EUR | - | Direct ownership | |
| Kristo Karjust 22.10.1979 (44) | 80% - 3 259.00 EUR | Board member | Direct ownership | Founder |
| 2019 24.11.2020 | 2020 30.06.2021 | 2021 05.07.2022 | 2022 03.07.2023 | |
|---|---|---|---|---|
| Total Revenue | 942 439 € | 874 457 € | 963 472 € | 1 054 596 € |
| Net profit (loss) for the period | 116 184 € | 120 522 € | 125 905 € | 150 898 € |
| Profit Margin | 12% | 14% | 13% | 14% |
| Current Assets | 440 637 € | 510 926 € | 298 058 € | 441 289 € |
| Fixed Assets | 16 745 € | 50 628 € | 408 011 € | 435 678 € |
| Total Assets | 457 382 € | 561 554 € | 706 069 € | 876 967 € |
| Current Liabilities | 17 341 € | 5 120 € | 43 052 € | 63 059 € |
| Non Current Liabilities | - | - | - | - |
| Total Liabilities | - | - | - | - |
| Share Capital | - | - | - | - |
| Equity | 440 041 € | 556 434 € | 663 017 € | 813 908 € |
| Employees | 1 | 1 | 1 | 1 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 230 164.84 € | - | 5 185.16 € | 3 |
| 2023 Q4 | 138 171.87 € | - | 5 745.64 € | 2 |
| 2023 Q3 | 303 819.03 € | - | 4 598.92 € | 3 |
| 2023 Q2 | 364 533.99 € | - | 5 263.36 € | 2 |
| 2023 Q1 | 87 187.68 € | 3 375.26 € | 3 399.66 € | 2 |
| 2022 Q4 | 178 582.58 € | 4 306.63 € | 3 238.69 € | 1 |
| 2022 Q3 | 106 106.75 € | 8 858.32 € | 3 201.95 € | 1 |
| 2022 Q2 | 298 909.74 € | 6 048.72 € | 3 014.1 € | 1 |
| 2022 Q1 | 243 672.63 € | 3 829.61 € | 3 113.75 € | 1 |
| 2021 Q4 | 118 959.36 € | - | 2 621.77 € | 1 |
| 2021 Q3 | 258 479.82 € | - | 2 350.59 € | 1 |
| 2021 Q2 | 293 269.23 € | - | 2 399.97 € | 1 |
| 2021 Q1 | 287 008.61 € | - | 2 031.67 € | 1 |
| 2020 Q4 | 36 174.48 € | - | 551.82 € | 1 |
| 2020 Q3 | 29 826.97 € | 6 887.06 € | 1 655.46 € | 1 |
| 2020 Q2 | 324 453.42 € | 4 666.9 € | 809.88 € | 1 |
| 2020 Q1 | 168 088.11 € | 2 389.82 € | 1 655.46 € | 1 |
